Global

SHERIDAN, WYOMING - December 8, 2025 - Canadian fintech Tuhk Inc. is stepping out of stealth with a US$6 million seed round to turn fragmented fraud data into a real-time collaboration fabric between merchants, banks and service providers, as the payments industry wrestles with a cybercrime threat measured in the trillions of dollars.

Fintech Veterans Target a US$10.5 Trillion Cybercrime Problem

Founded in 2025 by veterans from Ethoca and NuData Security, Toronto-based Tuhk is positioning itself as a "real-time data collaboration platform" at the intersection of fraud prevention and payments optimization. The seed financing is led by FINTOP, with strategic participation from Lloyds Banking Group and Capital One Ventures, signalling early alignment from major issuers and card partners.

SHERIDAN, WYOMING - December 8, 2025 - Teleste is sharpening its execution muscle in the fast-growing public safety and mobility market by appointing project delivery specialist Jaakko Keski-Nisula as Head of Project Management for its Public Safety and Mobility business unit, a new leadership role designed to boost delivery performance on complex, safety-critical infrastructure projects.

New leadership role targets large, complex public transport projects

Based in Turku, Finland, Keski-Nisula will join the business unit's Leadership Team and report to Senior Vice President Public Safety and Mobility, Valerian Sand. His remit: strengthen Teleste's project management capabilities across international deployments in public transport and security, where customers increasingly expect turnkey, integrated solutions with predictable timelines and service levels.

SHERIDAN, WYOMING - December 8, 2025 - Days after Johnson & Johnson reported a mid-stage failure for its anti-tau antibody posdinemab, Eisai is using the Clinical Trials on Alzheimer's Disease (CTAD) 2025 conference to argue that tau is still a viable target-if drug designers hit the right part of the protein-while investors and scientists pivot their attention to inflammation and vascular pathways.

Anti-tau Setbacks Raise the Bar for New Entrants

Tau-directed drugs have been among the most high-profile disappointments in Alzheimer's disease (AD) R&D. J&J's recent miss with posdinemab follows last year's Phase II failure of UCB's bepranemab and Eli Lilly's inability to replicate its amyloid success with the anti-tau candidate LY3372689. Collectively, these readouts have fed a narrative that tau may be an intractable or poorly understood target for disease modification.

SHERIDAN, WYOMING - December 8, 2025 - SprintRay's acquisition of the EnvisionTEC dental product portfolio marks a strategic step in the consolidation of the dental 3D printing market, expanding its materials ecosystem, reinforcing supply resilience and giving both SprintRay and EnvisionTEC users clearer long-term pathways in digital production.

What Changes for SprintRay Customers: More Materials, Same Workflow

For existing SprintRay practices and labs, the immediate impact is about breadth rather than disruption. The EnvisionTEC dental portfolio brings additional validated resin formulations that SprintRay is adapting for its own printers, which means customers gain more material options without having to invest in new hardware.

SHERIDAN, WYOMING - December 4, 2025 - Mavsign, a leading provider of secure offsite contracting and fraud prevention solutions for the automotive finance ecosystem, has strengthened its legal and compliance backbone by engaging Hudson Cook LLP to review and enhance its information security, privacy and customer-facing frameworks. The move underscores how digital contracting platforms are investing ahead of regulatory pressure to give lenders, fintechs and dealers greater confidence in remote identity verification and high-value transactions.

Reinforcing a Compliance-First Offsite Contracting Model

SHERIDAN, WYOMING - December 4, 2025 - London-based fashion house self-portrait is stepping deeper into the creator economy with the announcement that Academy Award-winning filmmaker Sean Baker will debut his new short film Sandiwara as part of the brand's Residency programme, starring fellow Oscar winner Michelle Yeoh and slated to premiere in February 2026. For the luxury and culture industries, the move signals how fashion labels are increasingly operating as full-fledged content studios, using film to extend brand equity far beyond the runway.

Residency as a Strategic Content Lab for the Brand

SHERIDAN, WYOMING - December 4, 2025 - MicroCloud Hologram Inc. is pushing deeper into quantum computing and AI with a new quantum-driven 3D intelligent model designed to automate high-precision 3D model and image generation for enterprise customers. Built on a modular, quantum-optimized architecture, the system aims to shrink development timelines, cut manual rework and give industrial users a more scalable backbone for holographic digital twins, LiDAR and advanced visualization workloads.

Quantum Meets 3D Modeling for Enterprise-Grade Workflows

At the core of MicroCloud's new system is a 3D modeling and image-processing stack that fuses quantum deep learning with classical AI. The model ingests massive, heterogeneous datasets-ranging from 3D modeling inputs to complex image streams-and uses quantum-enhanced algorithms to extract key features and automatically generate 3D assets that align with user-defined parameters.

SHERIDAN, WYOMING - December 4, 2025 - TELEO Capital portfolio company Sharpen Technologies, Inc. ("SharpenCX") is expanding its reach in the communications platform market with the acquisition of Ytel, Inc., adding developer-centric CPaaS capabilities to its cloud-native customer engagement stack. The deal positions SharpenCX to serve enterprises that want to unify contact center, telephony and programmable messaging on a single, AI-ready platform rather than relying on multiple point solutions.

Strategic move in a consolidating CX and CPaaS landscape

SHERIDAN, WYOMING - December 4, 2025 - Thumzup Media Corporation is moving quickly to shed its image as a niche social advertising startup and reposition itself as a diversified operator in digital-asset infrastructure, data-center capacity, and next-generation computation. Backed by fresh capital and a pipeline of deals, the Los Angeles-based company is steering toward businesses with more predictable cash flows and scalable hard assets.

From Social Ad Startup to Balance-Sheet Builder

Thumzup's strategic reset rests on a markedly stronger financial base. In August 2025, the company raised $50 million in a public offering, lifting total assets to approximately $52 million. That step-change in scale gives Thumzup, which previously operated with far leaner resources, a genuine platform to pursue acquisitions, infrastructure buildouts, and selective minority stakes across high-growth technology verticals.

SHERIDAN, WYOMING - December 4, 2025 - Life sciences dealmaking is regaining momentum after a period of macroeconomic caution, but new research from West Monroe shows that transaction volume alone will not determine who comes out ahead. Instead, success in the next wave of M&A will hinge on execution speed, AI and digital maturity, and the ability to integrate people and cultures without losing focus on the deal thesis.

Dealmaking Rebounds, but the Rules Have Changed

West Monroe's report, The Next Wave of Life Sciences M&A: Navigating Policy, Power, and Progress, combines practitioner insight with a survey of 250 private equity firms and strategic acquirers in life sciences. The findings point to a clear rebound in activity: 68% of respondents expect more acquisitions in the next two years, while only 7% plan no deals at all.